Portal de Periódicos da CAPES

Modifiable risk factors associated with deep sternal site infection after coronary artery bypass grafting

2000; Elsevier BV; Volume: 119; Issue: 1 Linguagem: Inglês

10.1016/s0022-5223(00)70224-8

1097-685X

William E. Trick, William E. Scheckler, Jerome I. Tokars, Kevin Jones, Mel L. Reppen, Elizabeth Smith, William R. Jarvis,

Orthopedic Infections and Treatments

Objective: Our objective was to identify risk factors for deep sternal site infection after coronary artery bypass grafting at a community hospital. Methods: We compared the prevalence of deep sternal site infection among patients having coronary artery bypass grafting during the study (January 1995–March 1998) and pre-study (January 1992–December 1994) periods. We compared any patient having a deep sternal site infection after coronary artery bypass graft surgery during the study period (case-patients) with randomly selected patients who had coronary artery bypass graft surgery but no deep sternal site infection during the same period (control-patients). Results: Deep sternal site infections were significantly more common during the study than during the pre-study period (30/1796 [1.7%] vs 9/1232 [0.7%]; P = .04). Among 30 case-patients, 29 (97%) returned to the operating room for sternal debridement or rewiring, and 2 (7%) died. In multivariable analyses, cefuroxime receipt 2 hours or more before incision (odds ratio = 5.0), diabetes mellitus with a preoperative blood glucose level of 200 mg/dL or more (odds ratio = 10.2), and staple use for skin closure (odds ratio = 4.0) were independent risk factors for deep sternal site infection. Staple use was a risk factor only for patients with a normal body mass index. Conclusions: Appropriate timing of antimicrobial prophylaxis, control of preoperative blood glucose levels, and avoidance of staple use in patients with a normal body mass index should prevent deep sternal site infection after coronary artery bypass graft operations. (J Thorac Cardiovasc Surg 2000;119:108-14)